Synthesis and structure–activity relationship studies of 1,3-disubstituted 2-propanols as BACE-1 inhibitors
Authors:
- Jordan Micheal AndersonJAJordan Micheal Anderson
- Anthony Lester MelendezAMAnthony Lester Melendez
- Roman ManetschRMRoman Manetsch
- 1 July 2012
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 22 (14) , 4740-4744
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- The secretases: enzymes with therapeutic potential in Alzheimer diseaseNature Reviews Neurology, 2010
- β-Secretase as a Therapeutic Target for Alzheimer's DiseaseNeurotherapeutics, 2008
- Aβ Oligomers – a decade of discoveryJournal of Neurochemistry, 2007
- In vivo inhibition of Aβ production by memapsin 2 (β‐secretase) inhibitorsJournal of Neurochemistry, 2004
- Alzheimer's Disease: Molecular Understanding Predicts Amyloid-Based TherapeuticsAnnual Review of Pharmacology and Toxicology, 2003
- The Amyloid Hypothesis of Alzheimer's Disease: Progress and Problems on the Road to TherapeuticsScience, 2002
- BACE knockout mice are healthy despite lacking the primary beta-secretase activity in brain: implications for Alzheimer's disease therapeuticsHuman Molecular Genetics, 2001
- Mice deficient in BACE1, the Alzheimer's β-secretase, have normal phenotype and abolished β-amyloid generationNature Neuroscience, 2001
- Human aspartic protease memapsin 2 cleaves the β-secretase site of β-amyloid precursor proteinProceedings of the National Academy of Sciences, 2000
- Alzheimer's disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid proteinBiochemical and Biophysical Research Communications, 1984